Meyer, A. ., Horton, D. ., Neugebauer, N. ., Wooters, T. ., , Dwoskin, L. ., & Bardo, M. . (2011). Tetrabenazine inhibition of monoamine uptake and methamphetamine behavioral effects: locomotor activity, drug discrimination and self-administration. Neuropharmacology, 61(4), 849-56. https://doi.org/10.1016/j.neuropharm.2011.05.033

Stairs, D. ., Neugebauer, N. ., & Bardo, M. . (2010). Nicotine and cocaine self-administration using a multiple schedule of intravenous drug and sucrose reinforcement in rats. Behavioural Pharmacology, 21(3), 182-93. https://doi.org/10.1097/FBP.0b013e32833a5c9e

Berry, J. ., Neugebauer, N. ., & Bardo, M. . (2012). Reinstatement of methamphetamine conditioned place preference in nicotine-sensitized rats. Behavioural Brain Research, 235(2), 158-65. https://doi.org/10.1016/j.bbr.2012.07.043 (Original work published 2012)

Neugebauer, N. ., Harrod, S. ., & Bardo, M. . (2010). Nicotine elicits methamphetamine-seeking in rats previously administered nicotine. Drug and Alcohol Dependence, 106(1), 72-8. https://doi.org/10.1016/j.drugalcdep.2009.07.018 (Original work published 2010)

Dwoskin, L. ., Pivavarchyk, M. ., Joyce, B. ., Neugebauer, N. ., Zheng, G. ., Zhang, Z. ., … Crooks, P. . Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence. Nebraska Symposium on Motivation. Nebraska Symposium on Motivation, 55, 31-63. https://doi.org/10.1007/978-0-387-78748-0_4 (Original work published 2009)

Rahman, S. ., Neugebauer, N. ., Zhang, Z. ., Crooks, P. ., Dwoskin, L. ., & Bardo, M. . (2008). The novel nicotinic receptor antagonist N,N’-dodecane-1,12-diyl-bis-3-picolinium dibromide decreases nicotine-induced dopamine metabolism in rat nucleus accumbens. European Journal of Pharmacology, 601(1-3), 103-5. https://doi.org/10.1016/j.ejphar.2008.10.037 (Original work published 2008)

Dwoskin, L. ., Joyce, B. ., Zheng, G. ., Neugebauer, N. ., Manda, V. ., Lockman, P. ., … Crooks, P. . (2007). Discovery of a novel nicotinic receptor antagonist for the treatment of nicotine addiction: 1-(3-Picolinium)-12-triethylammonium-dodecane dibromide (TMPD). Biochemical Pharmacology, 74(8), 1271-82. https://doi.org/10.1016/j.bcp.2007.07.021 (Original work published 2007)

Neugebauer, N. ., Harrod, S. ., Stairs, D. ., Crooks, P. ., Dwoskin, L. ., & Bardo, M. . (2007). Lobelane decreases methamphetamine self-administration in rats. European Journal of Pharmacology, 571(1), 33-8. https://doi.org/10.1016/j.ejphar.2007.06.003 (Original work published 2007)

Wooters, T. ., Neugebauer, N. ., Rush, C. ., & Bardo, M. . (2008). Methylphenidate enhances the abuse-related behavioral effects of nicotine in rats: intravenous self-administration, drug discrimination, and locomotor cross-sensitization. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology, 33(5), 1137-48. https://doi.org/10.1038/sj.npp.1301477

Rahman, S. ., Neugebauer, N. ., Zhang, Z. ., Crooks, P. ., Dwoskin, L. ., & Bardo, M. . (2007). The effects of a novel nicotinic receptor antagonist N,N-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB) on acute and repeated nicotine-induced increases in extracellular dopamine in rat nucleus accumbens. Neuropharmacology, 52(3), 755-63. https://doi.org/10.1016/j.neuropharm.2006.09.012